Dr. David Tom Cooke is Professor and Founding Chief of UC Davis Health Center’s Division of General Thoracic Surgery. He specializes in complex general thoracic surgery and thoracic oncology, with special clinical interests including lung cancers and surgery for malignant mesothelioma. Dr. Cooke is a national leader in robotic thoracic surgery. His skills include minimally
Dr. Jonathan Wesley Riess is a thoracic oncologist at the UC Davis Health Medical Center. As Medical Director of Thoracic Oncology, he relies on advances in diagnostics, targeted therapies, and immunotherapy in the care of patients with malignant mesothelioma, lung cancer, and other thoracic cancers. In addition to his clinical care, he is also actively
Dr. Ravi Salgia is the Professor and Chair of the Department of Medical Oncology & Therapeutics Research at City of Hope in Duarte, California. A board-certified medical oncologist and researcher, he is an expert in the treatment of lung cancer, malignant mesothelioma, and thymic malignancies. Dr. Salgia has over 30 years of award-winning accomplishments in
Dr. Rimner is a radiation oncologist and Scientific Director at the Comprehensive Cancer Center of Freiberg in Baden-Württemberg, Germany. He previously worked with a multidisciplinary team at Memorial Sloan Kettering Cancer Center to identify the best treatment options for patients diagnosed with thoracic cancers. He specializes in a wide range of malignancies, including lung cancer,
Dr. Pennell is a board-certified medical oncologist who has spent more than two decades in clinical practice, specializing in the treatment of thoracic malignancies, including malignant pleural mesothelioma and lung cancer. He now serves as Senior Vice President, Worldwide Head of Medical Affairs, Hematology & Oncology for Bristol Myers Squibb. Prior to this, he was
Dr. Zauderer is a leading expert and researcher specializing in caring for people with thoracic cancers, including malignant pleural mesothelioma. As Professor of Medicine of Westchester Medical Center’s Division of Hematology and Neoplastic Diseases and Medicine in the Division of Oncology, she works with a multidisciplinary team of thoracic surgeons, radiation oncologists, pulmonologists, pathologists, radiologists,
Dr. Prasad S. Adusumilli is a thoracic surgeon and cellular therapist at the renowned Memorial Sloan Kettering Cancer Center. Over a 20-year career, he has specialized in treating patients with lung cancer, malignant pleural mesothelioma, and metastatic cancers to the lung. He sees approximately 600 patients each year, focusing on early diagnosis and accurate staging
Dr. Richard James Battafarano is a thoracic surgeon in Johns Hopkins Department of Surgery. He is both the Director of the Division of General Thoracic Surgery and Johns Hopkins’ first regional director of general thoracic surgery. He has significant skill and experience in conducting complex surgical procedures in the treatment of chest diseases like pleural
Dr. Forde is an internist and oncologist dedicated to treating thoracic cancers like mesothelioma, and researching the impact of immunotherapy in the treatment of lung cancer and mesothelioma. He is currently an Associate Member of the Bloomberg Kimmel Institute for Cancer Immunotherapy and the director of the Thoracic Cancer Clinical Research Program at Johns Hopkins’
Dr. Albelda is one of the world’s most respected experts in the field of thoracic oncology. He is the William Maul Measey Professor of Medicine at the Perelman School of Medicine and Associate Director of the Pulmonary Division, Director of the Thoracic Oncology Research Laboratory, and co-Director of the Translational Center of Excellence for Lung